CVS Health's Aetna subsidiary exited the ACA marketplace in 2026 after years of losses, citing unsustainable medical loss ratios driven by high hospital utilization and inflated facility pricing. New analysis shows Aetna negotiated materially higher hospital rates for ACA members compared to commercial and Medicare populations, a structural disadvantage that made the business model unworkable.

This is not an isolated incident. Aetna cited ACA member claims exceeding expectations and CEO David Joyner explicitly stated there was no "near- or long-term pathway" to profitability in the product. The company's exit removes approximately 1 million covered lives from the ACA marketplace and signals a broader trend: major insurers are cherry-picking participation based on reimbursement economics rather than market-wide commitment. The underlying issue—hospital systems commanding premium rates for ACA business—affects all carriers. If Aetna couldn't absorb those costs, smaller regional carriers face even greater pressure. This is compounded by tighter federal margins on ACA plans: medical loss ratio rules limit insurer profit, so cost inflation hits carrier net income directly.

For primary care practices, federally qualified health centers (FQHCs), and hospital-based providers relying on ACA revenue, Aetna's exit means one fewer commercial payer and likely increased patient mix volatility. Remaining ACA carriers may tighten prior authorization or raise cost-sharing to offset losses. For hospital systems and specialists, expect continued pressure on hospital-negotiated rates in ACA plans—if large carriers are exiting, smaller payers have less negotiating power against facility demands. DSO operators should model ACA membership loss and corresponding revenue impact by region.

What to watch: Q2 2026 earnings from UnitedHealth, Cigna, and Humana for ACA membership trends and profitability disclosures.